HomeInsightsStock Comparison

Gennex Laboratories Ltd vs Sms Lifesciences India Ltd Stock Comparison

Gennex Laboratories Ltd vs Sms Lifesciences India Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Gennex Laboratories Ltd is ₹ 13.6 as of 16 Jul 15:06.
  • The P/E Ratio of Gennex Laboratories Ltd changed from 12.4 on March 2020 to 27.2 on March 2024 . This represents a CAGR of 17.01% over 5 yearsThe P/E Ratio of SMS Lifesciences India Ltd changed from 5.2 on March 2020 to 22.6 on March 2024 . This represents a CAGR of 34.16% over 5 years.
  • The Market Cap of Gennex Laboratories Ltd changed from ₹ 23.53 crore on March 2020 to ₹ 359.37 crore on March 2024 . This represents a CAGR of 72.50% over 5 yearsThe Market Cap of SMS Lifesciences India Ltd changed from ₹ 52.91 crore on March 2020 to ₹ 205.21 crore on March 2024 . This represents a CAGR of 31.14% over 5 years.
  • The revenue of Gennex Laboratories Ltd for the Mar '25 is ₹ 44.16 crore as compare to the Dec '24 revenue of ₹ 40.01 crore. This represent the growth of 10.37% The revenue of SMS Lifesciences India Ltd for the Mar '25 is ₹ 91.45 crore as compare to the Dec '24 revenue of ₹ 84.66 crore. This represent the growth of 8.02%.
  • The ebitda of Gennex Laboratories Ltd for the Mar '25 is ₹ 5.85 crore as compare to the Dec '24 ebitda of ₹ 7.15 crore. This represent the decline of -18.18% The ebitda of SMS Lifesciences India Ltd for the Mar '25 is ₹ 9.76 crore as compare to the Dec '24 ebitda of ₹ 12.81 crore. This represent the decline of -23.81%.
  • The net profit of Gennex Laboratories Ltd changed from ₹ 2.85 crore to ₹ 3.07 crore over 8 quarters. This represents a CAGR of 3.79% The net profit of SMS Lifesciences India Ltd changed from ₹ -3.83 crore to ₹ 3.48 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Gennex Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of SMS Lifesciences India Ltd changed from 3.44 % on March 2021 to 3.47 % on March 2024 . This represents a CAGR of 0.22% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Gennex Laboratories Ltd

  • Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) was incorporated on June 25, 1985.
  • The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007. The Company is one of the leading manufacturers and exporters of Active pharmaceutical ingredients and Intermediates.
  • It is engaged in manufacturing and marketing of bulk drugs and intermediates. Gennex is among the leading Vertically Integrated' pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal.
  • The company thrives on the strength of its exports to various countries viz.
  • Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and Others.

About SMS Lifesciences India Ltd

  • SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006.
  • The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector.
  • The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016. The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates.
  • The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments.

Gennex Laboratories Ltd News Hub

News

Gennex Laboratories to discuss results

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 30 May...

Read more

21 May 2025 18:32

News

Gennex Laboratories to hold board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 Feb...

Read more

04 Feb 2025 10:33

News

Gennex Laboratories schedules board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 Nov...

Read more

07 Nov 2024 14:11

News

Gennex Laboratories AGM scheduled

Gennex Laboratories announced that the 39th Annual General Meeting (AGM) of the company wi...

Read more

11 Sep 2024 17:20

News

Gennex Laboratories to hold board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 6 Sept...

Read more

28 Aug 2024 15:49

News

Gennex Laboratories to discuss results

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 Aug...

Read more

07 Aug 2024 17:36

SMS Lifesciences India Ltd News Hub

News

SMS Lifesciences India Ltd leads gainers in 'B' group

Magellanic Cloud Ltd, Fischer Medical Ventures Ltd, Global Surfaces Ltd and 20 Microns Ltd...

Read more

16 Jul 2025 12:15

News

Board of SMS LifeSciences India recommends final dividend

SMS LifeSciences India announced that the Board of Directors of the Company at its meeting...

Read more

30 May 2025 11:19

News

SMS LifeSciences India to announce Quarterly Result

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 29 ...

Read more

24 May 2025 11:21

News

SMS Lifesciences India spurts as Q3 PAT jumps 18% YoY to Rs 5 cr

Revenue from operations was at Rs 84.60 crore in the third quarter of FY25, marking a grow...

Read more

13 Feb 2025 12:51

News

SMS LifeSciences India to announce Quarterly Result

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

08 Feb 2025 16:22

News

SMS LifeSciences India to conduct board meeting

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 13 ...

Read more

09 Nov 2024 12:30

SWOT Analysis Of Gennex Laboratories Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of SMS Lifesciences India Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gennex Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for SMS Lifesciences India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Gennex Laboratories Ltd and SMS Lifesciences India Ltd

Which company has a larger market capitalization, Gennex Laboratories Ltd or SMS Lifesciences India Ltd?

Market cap of Gennex Laboratories Ltd is 322 Cr while Market cap of SMS Lifesciences India Ltd is 345 Cr

What are the key factors driving the stock performance of Gennex Laboratories Ltd and SMS Lifesciences India Ltd?

The stock performance of Gennex Laboratories Ltd and SMS Lifesciences India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gennex Laboratories Ltd and SMS Lifesciences India Ltd?

As of July 16, 2025, the Gennex Laboratories Ltd stock price is INR ₹14.19. On the other hand, SMS Lifesciences India Ltd stock price is INR ₹1143.8.

How do dividend payouts of Gennex Laboratories Ltd and SMS Lifesciences India Ltd compare?

To compare the dividend payouts of Gennex Laboratories Ltd and SMS Lifesciences India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions